By Josh White
Date: Tuesday 05 Mar 2024
(Sharecast News) - Shares in cell and gene therapy specialist Oxford Biomedica were jumping on Tuesday afternoon, after the company updated the market on its medium-term financial guidance.
Total Voting Rights | 02-Apr-2024 | 07:00 | RNS |
Update on CDMO Services | 20-Mar-2024 | 07:00 | RNS |
Board Changes | 11-Mar-2024 | 07:00 | RNS |
Updated Financial Guidance and 2023 Trading | 05-Mar-2024 | 07:00 | RNS |
Total Voting Rights | 01-Mar-2024 | 07:00 | RNS |
Need to know: Opec cuts forecast ... Tesco cuts ... | 16-Aug-2008 | Times |
Need to know | 10-May-2008 | Times |
DSG International may be losing its spark | 12-Feb-2008 | Telegraph |
Oxford BioMedica clinches $690m licensing deal f... | 29-Mar-2007 | The Independent |
Oxford Biomedica seals €518m deal with Sanofi ov... | 29-Mar-2007 | Times |
No recent information was found.
Currency | UK Pounds |
Share Price | 220.00p |
Change Today | 1.50p |
% Change | 0.69 % |
52 Week High | 470.00 |
52 Week Low | 166.80 |
Volume | 157,766 |
Shares Issued | 100.00m |
Market Cap | £220.00m |
RiskGrade | 125 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 1 |
Buy | 3 |
Neutral | 6 |
Sell | 0 |
Strong Sell | 0 |
Total | 10 |
No dividends found |
Time | Volume / Share Price |
17:05 | 2,500 @ 220.00p |
16:35 | 32,280 @ 220.00p |
16:35 | 1,113 @ 220.00p |
16:35 | 878 @ 220.00p |
16:35 | 785 @ 220.00p |
You are here: research